Leslie Weinstein, MD is a
Otolaryngology physician based in Daly City, California. Leslie Weinstein is licensed to practice in California (license number G76353) and her current practice location is 1800 Sullivan Ave, Suite 503, Daly City, California. She can be reached at her office (for appointments etc.) via phone at
(650) 757-7127.
NPI number for Leslie Weinstein is 1730298431 and her current mailing address is 1800 Sullivan Ave, Suite 503, Daly City, California. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1730298431.
Physician's Profile
| Full Name | Leslie Weinstein |
|---|
| Gender | Female |
|---|
| Speciality | Otolaryngology |
|---|
| Location | 1800 Sullivan Ave, Daly City, California |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1730298431
- Provider Enumeration Date: 08/29/2006
- Last Update Date: 07/08/2007
Medical Identifiers
Medical identifiers for Leslie Weinstein such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
| 1730298431 | NPI | - | NPPES |
| 00G763530 | Medicaid | CA | |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
| 207Y00000X | Otolaryngology | G76353 (California) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Leslie Weinstein is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
Leslie Weinstein, MD 1800 Sullivan Ave, Suite 503, Daly City, CA 94015-2225 Ph: (650) 757-7127 | Leslie Weinstein, MD 1800 Sullivan Ave, Suite 503, Daly City, CA 94015-2225 Ph: (650) 757-7127 |
Reviews and Comments